Author

Laura Mendoza‐García

Consejo Superior de Investigaciones CientíficasORCID 0000-0002-9964-8127Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Ana de Lucas‐RiusiD· 3 shared Blanca Dies López-AyllóniD· 3 shared Juan J. GarridoiD· 3 shared María MontoyaiD· 3 shared Raúl Fernández‐RodrígueziD· 3 shared Tránsito García‐GarcíaiD· 3 shared Juozas GrigasiD· 2 shared Miguel Padilla‐BlancoiD· 2 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Ana de Lucas‐RiusORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologybioRxivPreprintAug 4, 2026

A single Omicron mutation reshapes ORF3a-driven host-cell remodelling

Ana de Lucas‐Rius, Miguel Padilla‐Blanco, Unai Merino Herrán…·María Montoya

This study identifies how a single mutation in the Omicron variant of SARS-CoV-2's ORF3a protein alters its host-cell remodelling effects, shifting from lipid accumulation to preserving Golgi structure.

DOI 10.64898/2026.08.02.742305

humanproteomics

ImmunologybioRxivPreprintApr 1, 2026

Omicron-Enhanced Immunosuppressive Effects of SARS-CoV-2 ORF3a and ORF9b Accessory Proteins on Monocytic Inflammatory Response

Juozas Grigas, Miguel Padilla‐Blanco, Unai Merino Herrán…·María Montoya

This study shows that SARS-CoV-2 accessory proteins ORF3a and ORF9b suppress monocytic inflammatory responses, with Omicron variants enhancing this effect.

DOI 10.64898/2026.03.31.715496

humanproteomics

ImmunologybioRxivPreprintSep 25, 2024

Inflammation cellular platform (INCEPLAT) for testing anti-inflammatory compounds for SARS-CoV-2

Blanca D. López‐Ayllón, Laura Mendoza‐García, Ana de Lucas‐Rius…·María Montoya

The paper develops a cellular platform using SARS-CoV-2 ORF-expressing A549 cells to screen anti-inflammatory compounds from Fasciola hepatica, showing FhNEJ extract reduces IL11 levels.

1 citation

humanbulk RNA-seq